Why Philippine health tourism keeps falling behind

Recent public debates about tourism—its pricing, value, and credibility — have drawn attention to a broader issue that extends beyond leisure travel. At its core is a simple but uncomfortable question: is the Philippines consistently delivering experiences that match what it promises?

Medical tourism sits at the most demanding end of that spectrum. It is not a segment that can rely on branding or promotion. It succeeds only when systems, standards, and trust are firmly in place.

The Philippines has long expressed its desire to become a serious medical tourism destination.

The country has many of the necessary ingredients: internationally respected clinicians, globally deployed nurses, a steadily modernizing private hospital sector and cost advantages compared with its regional neighbors. Yet despite this, the Philippines still attracts only a tiny fraction of the medical travelers who go to Thailand, Singapore and Malaysia.

This gap became clearer during a recent health tourism roundtable organized by the Department of Health, where more than 30 hospitals, clinics, wellness operators and industry groups came together for what was, notably, one of the rare multi-sector dialogues on this topic.

The discussion formed part of ongoing internal work at DoH, including a study for which stakeholders were convened by Undersecretary Emmie Liza Perez Chiong.

Chiong remarked that the inputs from these actors would feed into ongoing DoH work and that she was drawing from her experience and network in the Department of Trade and Industry, Philippine International Trading Corp., and other agencies to improve the coherence of inter-agency efforts.

What emerged from the discussion was not a lack of ambition, but a set of persistent structural constraints that continue to hold the Philippines back.

Credibility gap starts at home

One of the most telling — and often underappreciated — signals is the steady outflow of Filipino patients seeking care overseas. Each year, large numbers of affluent and middle-class Filipinos travel to Singapore, Thailand and elsewhere for cancer treatment, cardiology, IVF, advanced diagnostics and even routine second opinions.

This matters because medical tourism cannot succeed if a country struggles to retain its own patients. Domestic patient leakage is not merely a revenue issue; it is a credibility problem. If Filipino patients with means and access consistently choose foreign systems over local ones, international patients and insurers draw the same conclusion. The retention of domestic patients is the first and most important test of trust.

Fragmented pathways deter foreign patients

Another major constraint is the absence of a national referral and coordination system.

Countries such as Thailand and Singapore have well-defined pathways that filter cases, match patients to the appropriate facilities and uphold quality and safety standards.

By contrast, foreign patients entering the Philippine system usually do so informally — through personal networks, brokers, or social media — without a unified entry point or predictable patient journey.

This informality immediately discourages international insurers. Without standardized pathways, clear accountability and reliable follow-up, insurers cannot justify directing patients to the Philippines, regardless of individual provider quality.

Unclear competitive identity

The roundtable also highlighted the country’s lack of a clear competitive identity. Successful medical tourism destinations know exactly what they are known for. Thailand is often associated with aesthetics, gender-affirming care and integrative wellness. Singapore is known for oncology, complex surgery and clinical excellence. Malaysia has positioned itself around maternity, dental and Muslim-friendly medical tourism.

The Philippines, meanwhile, has its own strengths — from advanced radiation therapy and oncology programs to rehabilitation, dental and aesthetic services, English-speaking care teams and competitive surgical pricing — but these strengths remain fragmented and poorly signposted internationally. Without a clear value proposition, they remain largely invisible to global markets.

Standards, accreditation, insurer trust

Accreditation and certification remain another barrier. Foreign patients and insurers consistently ask a simple but critical question: how professional are your professionals? In the Philippines, licensing pathways remain inconsistent and some specialties lack cohesive national standards.

As a result, many international insurance networks exclude Philippine hospitals from their approved provider lists, even when comparable facilities exist locally. Without recognized accreditation, insured medical travel simply does not flow.

Coordination gaps across government

Inter-agency fragmentation compounds these issues. For medical tourism to succeed, it must be embedded within national investment and development frameworks and supported by coordination across the DoH, Department of Tourism, Board of Investments, Bureau of Immigration, Food and Drug Administration and local governments.

Other countries have moved more decisively in aligning healthcare delivery, tourism infrastructure, and regulation into coherent ecosystems. The Philippines, by comparison, continues to operate largely in silos.

Another limiting factor is the absence of consolidated data. Private hospitals hold most information on patient flows, outcomes and case mix, but these data are not routinely shared with the DoH. Without shared datasets, the country cannot benchmark performance, identify priority markets, or design evidence-based strategies. Planning remains fragmented and reactive.

Creating space to experiment

One practical way forward is to designate a limited medical tourism pilot zone where new strategies can be tested in a controlled environment. Rather than attempting nationwide rollout, such a zone would allow regulators and providers to experiment with patient pathways, accreditation standards, inter-agency coordination and data sharing — while containing risk and learning quickly from what works and what does not.

Focused pilots allow governments to refine rules, align agencies and build credibility before scaling. For the Philippines, a limited pilot would reduce political and operational risk, avoid overpromising and provide concrete evidence to guide future national decisions.

From discussion to coherence

The roundtable also revealed reasons for cautious optimism. There is growing willingness — within both government and the private sector — to rethink the country’s approach and improve coordination.

The DoH’s openness to gather inputs and revisit frameworks is a constructive first step. However, the private sector must also move beyond fragmented, independent action. Acting together is now essential.

A credible national strategy will require sustained engagement: clearer certification and licensing systems, unified patient pathways, inter-agency alignment, a sharper national identity and shared data to guide decision-making.

The Philippines has the talent and facilities to compete. What it needs now is coherence — and a durable partnership between government and private institutions that will finally bring health tourism into a unified national direction.